MDXG FY 2011 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$669M

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+883.7% YoY

Gross Profit

$5M59.4% margin

Operating Income

-$10M-125.8% margin

Net Income

-$10M-131.4% margin

EPS (Diluted)

$-0.14

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$27M

Total Liabilities

$15M

Stockholders' Equity

$12M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$788,874	+883.7%
Gross Profit	$5M	-$931,189	+594.6%
Operating Income	-$10M	-$11M	+7.3%
Net Income	-$10M	-$11M	+10.7%